DR.Chip Biotechnology Incorporation announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 104.489 million compared to TWD 61.792 million a year ago. Operating loss was TWD 19.207 million compared to TWD 25.892 million a year ago. Net loss was TWD 11.865 million compared to TWD 25.070 million a year ago. Basic loss per share was TWD 0.25 compared to TWD 0.54 a year ago.